Benefícios da psicoterapia assistida por MDMA para pacientes diagnosticados com TEPT
Gustavo Souza Fioroti, Natália Corassa Pinheiro, Fábio Nogueira Pereira
Revista Científica Faesa June 1, 2024 DOI: 10.5008/1809.7367.272 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Double-blind Peer reviewed |
|---|---|
| Population | Patients diagnosed with post-traumatic stress disorder (PTSD) |
| Topics | MDMA |
| Key points | Argues that MDMA-assisted psychotherapy may be a safe and effective clinical option for PTSD, citing double-blind studies in which some participants received MDMA and others placebo alongside psychotherapy; the authors report significant results and efficacy even for treatment-resistant conditions. |
Abstract
This essay discusses the potential clinical use of 3,4methylenedioxymethamphetamine (MDMA) with patients diagnosed with Post Traumatic Stress Disorder (PTSD). We present a brief history of the use of consciousness-altering substances from ancient times to the present as well as recent research on psychedelic assisted psychotherapy (PAP). Double blind investigation in which some of the participants received MDMA and others placebo as an assistant to their psychotherapy process. Results in several studies revealed significant results, a high profile of safety and efficacy even for the treatment of resistant conditions.